amazon digital currency Block

The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)Song Zhexie, Samsung Semiconductor: I feel the great potential of the semiconductor market in China and I am very willing to grow with China customers. At the Shanghai IC Industry Development Forum 2024 held today, Song Zhe Xie, general manager of Samsung Semiconductor Foundry Greater China, said that the semiconductor industry in China is not only growing in scale, but also improving the development quality of the whole industry from the product upgrading and process evolution of Samsung semiconductor customers. The development of new quality productivity is helping the semiconductor market in China to flourish. In the cooperation with customers in China, I feel the great potential of the semiconductor market in China, and I am very willing to grow with customers in China, and provide diversified solutions to meet the needs of customers in China to enhance the competitiveness of products.Senior energy safety official: Poland will start looking for partners for the construction of the second nuclear power plant in early 2025.

Chilean Mining Association (SONAMI): Copper production in Chile is affected by poor project performance.US officials said that the United States is focused on providing Ukraine with the air defense system it needs to defend against Russian missiles and drones.Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.

The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)The USD/JPY intraday increase of USD/JPY expanded to 0.50% and is now reported at 152.72.Beijing Auto: BAIC Investment and Hyundai Motor invested US$ 1.095 billion in Beijing Hyundai. Beijing Auto announced that on December 11, 2024, BAIC Investment and Hyundai Motor entered into an agreement, and both parties agreed to jointly invest US$ 1.095 billion in Beijing Hyundai according to the proportion of their respective registered capital, and both parties invested US$ 548 million respectively. The capital injection will be carried out in stages. After the capital injection is completed, the registered capital of Beijing Hyundai will increase to US$ 4.074 billion, and Beijing Hyundai will still be owned by BAIC Investment and Hyundai Motor respectively, and will continue to be accounted for as a joint venture of the Company.